TSX runs higher on rate cut expectations
Merus N.V. (NASDAQ:MRUS), a company specializing in pharmaceutical preparations, announced the results of its annual general meeting held on May 21, 2025. The meeting saw a significant turnout, with approximately 89.20% of the outstanding common shares represented.
The shareholders voted on several key proposals, all of which were outlined in the company’s definitive proxy statement filed on April 24, 2025. The approved items included the adoption of the Dutch statutory annual accounts for the financial year 2024, the appointment of KPMG Accountants N.V. as the company’s external auditor for the financial year 2025, and the release of each board member from liability for their duties during the financial year 2024.
Additionally, the shareholders re-appointed Anand Mehra, M.D., as a non-executive director until the 2027 annual general meeting and Maxine Gowen, Ph.D., as a non-executive director until the 2029 annual general meeting. The authorization for the board of directors to acquire shares in the company’s capital was granted, and on an advisory basis, the compensation of the named executive officers was approved.
The voting results for the adoption of the Dutch statutory annual accounts were 57,716,793 for, 29 against, 18,530 abstentions, and 3,976,898 broker non-votes. For the appointment of KPMG Accountants N.V., the votes were 61,535,776 for, 168,451 against, 8,023 abstentions, and no broker non-votes. The release of board members from liability saw 57,655,084 votes for, 21,373 against, 58,895 abstentions, and 3,976,898 broker non-votes.
The re-appointment of Anand Mehra, M.D., had 53,233,592 votes for, 3,226,082 against, 1,275,678 abstentions, and 3,976,898 broker non-votes. The re-appointment of Maxine Gowen, Ph.D., received 57,605,971 votes for, 121,866 against, 7,515 abstentions, and 3,976,898 broker non-votes. The authorization for the board to acquire company shares garnered 57,698,272 votes for, 1,912 against, 35,168 abstentions, and 3,976,898 broker non-votes. Lastly, the compensation of executive officers was approved with 55,982,398 votes for, 1,682,719 against, 70,235 abstentions, and 3,976,898 broker non-votes.
The results of the meeting reflect shareholder support for the current direction of the company’s leadership and financial management. The information contained in this article is based on the company’s recent SEC filing.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.